UroToday.com - In the Journal of the National Cancer Institute, Dr. Elizabeth Wever and investigators from Rotterdam report that PSA screening in detecting prostate cancer (CaP) was lower in the United States than in the European Randomized Study of Screening for Prostate Cancer-Rotterdam (ERSPC-Rotterdam). This study compared PSA screening performance for detecting CaP in the ERSPC-Rotterdam with the US population...
The American Diabetes Association issues the following statement on the health reform bill passing in the U.S. House of Representatives today. "Today is a day for celebration for the 23.6 million American children and adults who are living with diabetes. The passage of health reform by the House of Representatives finally tears down the wall that keeps people with diabetes from the health care they need," commented Nash Childs, PE, Chair of the Board, American Diabetes Association...
Carl Zeiss Meditec announced that the U.S. Food and Drug Administration (FDA) has granted a 510(k) Class II clearance for the Humphrey® Field Analyzer (HFA) II-i with Guided Progression Analysis™ (GPA) software. The world's most widely used automated perimeter is now the only perimeter with GPA software that has received clearance from the FDA to specifically assess the rate of visual field loss over time. The FDA 510(k) Number K093213 Indications for Use states: "The Carl Zeiss Meditec, Inc. Guided Progression Analysis is a software module for the Humphrey Field Analyzer...